AbbVie (NYSE: ABBV) announced it is presenting clinical data from multiple investigational lung cancer programs at the 2026 World Conference ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE